Statin Penetration In U.S. Is Example Of Benefit Of Rx Promotion - BCG Study
Executive Summary
The relatively high use of HMG-CoA reductase inhibitors to treat cholesterol in the U.S. is an example of the more rapid penetration of innovative drug classes in less controlled markets, a Boston Consulting Group study maintains.